Novel compounds with dual S1P receptor agonist and histamine H 3 receptor antagonist activities act protective in a mouse model of multiple sclerosis

January 6, 2021
Neuropharmacology
https://pubmed.ncbi.nlm.nih.gov/33460688

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/33460688

Research summary

Key outcome of the study

Mouse model

TARGET:

Keywords

Technical specifications

Related products

Catalogue product

No items found.

Customized product

No items found.